Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Kenvue to Announce First Quarter 2024 Results on May 7, 2024


Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue, will announce its financial results for the first quarter ending March 31, 2024, before market open on May 7, 2024.

The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results. The conference call can be accessed by dialing 888-672-2415 from the U.S. or +1 646-307-1952 from international locations. The conference ID for all callers is 14840. A live webcast of the conference call will be available at investors.kenvue.com. A replay will be available after the live event.

About Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.


These press releases may also interest you

at 16:40
TriSalus Life Sciences Inc., , today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm. The capital is expected to provide financial flexibility to support the execution of strategic...

at 16:30
Vanda Pharmaceuticals Inc. (Vanda) today announced it will release results for the first quarter 2024 on Wednesday, May 8, 2024, after the market closes....

at 16:30
Community Healthcare Trust Incorporated (the "Company") today announced results for the three months ended March 31, 2024. The Company reported net income for the three months ended March 31, 2024 of approximately $3.7 million, or $0.11 per diluted...

at 16:16
Net income of $395.2 million ($2.04 per diluted common share) for the first quarter of 2024; after-tax adjusted operating income was $409.9 million ($2.12 per diluted common share).Results reflect a growing top-line with core operations premium...

at 16:15
Exelixis, Inc. today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated commercial, clinical and pipeline development...

at 16:15
Rasmussen University today announced the expansion of its Bloomington Bachelor of Science in Nursing (BSN) program to the Hennepin/Anoka campus. Through this expansion, all Rasmussen University campuses in the Twin Cities area will now offer the...



News published on and distributed by: